Connection

Richard Silver to Humans

This is a "connection" page, showing publications Richard Silver has written about Humans.
Connection Strength

1.214
  1. PACK syndrome: A case series and review. Am J Med Sci. 2023 04; 365(4):321-328.
    View in: PubMed
    Score: 0.033
  2. Voriconazole-associated periostitis presenting as hypertrophic osteoarthropathy following lung transplantation report of two cases and review of the literature. Semin Arthritis Rheum. 2019 10; 49(2):319-323.
    View in: PubMed
    Score: 0.025
  3. Systemic sclerosis: Choosing patients wisely when treating interstitial lung disease. Nat Rev Rheumatol. 2017 08; 13(8):455-456.
    View in: PubMed
    Score: 0.022
  4. Management of Systemic-Sclerosis-Associated Interstitial Lung Disease. Rheum Dis Clin North Am. 2015 Aug; 41(3):439-57.
    View in: PubMed
    Score: 0.019
  5. Update on scleroderma-associated interstitial lung disease. Curr Opin Rheumatol. 2014 Nov; 26(6):630-6.
    View in: PubMed
    Score: 0.019
  6. Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis. J Comput Assist Tomogr. 2014 Mar-Apr; 38(2):163-8.
    View in: PubMed
    Score: 0.018
  7. Editorial: molecular insights into systemic sclerosis-associated interstitial lung disease. Arthritis Rheumatol. 2014 Mar; 66(3):485-7.
    View in: PubMed
    Score: 0.018
  8. Systemic sclerosis and the heart. Rheum Dis Clin North Am. 2014 Feb; 40(1):87-102.
    View in: PubMed
    Score: 0.017
  9. Factors associated with oral hygiene practices among adults with systemic sclerosis. Int J Dent Hyg. 2014 Aug; 12(3):180-6.
    View in: PubMed
    Score: 0.017
  10. Factors associated with gingival inflammation among adults with systemic sclerosis. Int J Dent Hyg. 2014 Feb; 12(1):55-61.
    View in: PubMed
    Score: 0.017
  11. Racial differences between blacks and whites with systemic sclerosis. Curr Opin Rheumatol. 2012 Nov; 24(6):642-8.
    View in: PubMed
    Score: 0.016
  12. Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil. 2012; 34(1):84-9.
    View in: PubMed
    Score: 0.015
  13. Paraspinal tumoral calcinosis in a child with systemic sclerosis/myositis overlap. Pediatr Radiol. 2011 Sep; 41(9):1216-8.
    View in: PubMed
    Score: 0.015
  14. Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis. Clin Exp Rheumatol. 2011 Mar-Apr; 29(2 Suppl 65):S26-32.
    View in: PubMed
    Score: 0.015
  15. Biomarkers of scleroderma lung disease: recent progress. Curr Rheumatol Rep. 2011 Feb; 13(1):44-50.
    View in: PubMed
    Score: 0.014
  16. Acute onset of dyspnea in an HIV patient. Am J Med. 2010 Nov; 123(11):999-1000.
    View in: PubMed
    Score: 0.014
  17. Pulmonary manifestations of scleroderma and mixed connective tissue disease. Clin Chest Med. 2010 Sep; 31(3):433-49.
    View in: PubMed
    Score: 0.014
  18. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence. Semin Arthritis Rheum. 2010 Dec; 40(3):241-9.
    View in: PubMed
    Score: 0.014
  19. Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. Arthritis Rheum. 2009 Nov; 60(11):3455-64.
    View in: PubMed
    Score: 0.013
  20. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. Semin Arthritis Rheum. 2010 Aug; 40(1):73-88.
    View in: PubMed
    Score: 0.012
  21. Endothelin and scleroderma lung disease. Rheumatology (Oxford). 2008 Oct; 47 Suppl 5:v25-6.
    View in: PubMed
    Score: 0.012
  22. Outcome measures in the lung. Rheumatology (Oxford). 2008 Oct; 47 Suppl 5:v48-50.
    View in: PubMed
    Score: 0.012
  23. Histopathology and bronchoalveolar lavage. Rheumatology (Oxford). 2008 Oct; 47 Suppl 5:v62-4.
    View in: PubMed
    Score: 0.012
  24. Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration. Am J Physiol Lung Cell Mol Physiol. 2008 Oct; 295(4):L603-11.
    View in: PubMed
    Score: 0.012
  25. Captive of art, not disease. Paul Klee and his illness, scleroderma. Pharos Alpha Omega Alpha Honor Med Soc. 2008; 71(1):16-24.
    View in: PubMed
    Score: 0.012
  26. Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways. Arthritis Rheum. 2007 Oct; 56(10):3468-77.
    View in: PubMed
    Score: 0.011
  27. Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis. Arthritis Rheum. 2007 Jul; 56(7):2432-42.
    View in: PubMed
    Score: 0.011
  28. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol. 2006 Feb; 33(2):263-8.
    View in: PubMed
    Score: 0.010
  29. New developments in scleroderma interstitial lung disease. Curr Opin Rheumatol. 2005 Nov; 17(6):737-45.
    View in: PubMed
    Score: 0.010
  30. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Ann Rheum Dis. 2005 Sep; 64(9):1387.
    View in: PubMed
    Score: 0.010
  31. Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study. Curr Rheumatol Rep. 2005 Apr; 7(2):135-41.
    View in: PubMed
    Score: 0.010
  32. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol. 2005 Jan; 32(1):51-7.
    View in: PubMed
    Score: 0.009
  33. Thrombin-mediated cellular events in pulmonary fibrosis associated with systemic sclerosis (scleroderma). Clin Exp Rheumatol. 2004 Jan-Feb; 22(3 Suppl 33):S38-46.
    View in: PubMed
    Score: 0.009
  34. Use of NSAIDs and COX-2 inhibitors in children with musculoskeletal disorders. J Pediatr Orthop. 2003 Nov-Dec; 23(6):794-9.
    View in: PubMed
    Score: 0.009
  35. Nodular scleroderma: case report and literature review. J Rheumatol. 2003 Nov; 30(11):2500-2.
    View in: PubMed
    Score: 0.009
  36. Treatment of rheumatoid arthritis then and now. J S C Med Assoc. 2003 Oct; 99(10):321.
    View in: PubMed
    Score: 0.009
  37. Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA. J Rheumatol. 2003 Jun; 30(6):1238-43.
    View in: PubMed
    Score: 0.008
  38. Assessment of lung involvement. Clin Exp Rheumatol. 2003; 21(3 Suppl 29):S19-23.
    View in: PubMed
    Score: 0.008
  39. Cytochrome P2 polymorphisms and susceptibility to scleroderma: comment on the article by Povey et al. Arthritis Rheum. 2001 Nov; 44(11):2705-6.
    View in: PubMed
    Score: 0.008
  40. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis. J Rheumatol. 2001 Sep; 28(9):2031-7.
    View in: PubMed
    Score: 0.007
  41. Cannabis use while trying to conceive: a prospective cohort study evaluating associations with fecundability, live birth and pregnancy loss. Hum Reprod. 2021 04 20; 36(5):1405-1415.
    View in: PubMed
    Score: 0.007
  42. Nodular Regenerative Hyperplasia of the Liver in Rheumatic Disease: Cases and Review of the Literature. J Investig Med High Impact Case Rep. 2021 Jan-Dec; 9:23247096211044617.
    View in: PubMed
    Score: 0.007
  43. Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol. 2000 Nov; 12(6):520-6.
    View in: PubMed
    Score: 0.007
  44. Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension. Chest. 2000 Oct; 118(4):1077-82.
    View in: PubMed
    Score: 0.007
  45. Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial. Ann Rheum Dis. 2020 05; 79(5):618-625.
    View in: PubMed
    Score: 0.007
  46. Neonatal alloimmune thrombocytopenia: antenatal management. Am J Obstet Gynecol. 2000 May; 182(5):1233-8.
    View in: PubMed
    Score: 0.007
  47. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020 03; 8(3):304-320.
    View in: PubMed
    Score: 0.007
  48. Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation. Am J Respir Cell Mol Biol. 2000 Feb; 22(2):235-43.
    View in: PubMed
    Score: 0.007
  49. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020 01 25; 395(10220):285-293.
    View in: PubMed
    Score: 0.007
  50. Recurrent pregnancy loss: summary and clinical recommendations. Semin Reprod Med. 2000; 18(4):433-40.
    View in: PubMed
    Score: 0.007
  51. HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):552-562.
    View in: PubMed
    Score: 0.007
  52. Assessment and management of scleroderma lung disease. Curr Opin Rheumatol. 1999 Nov; 11(6):508-13.
    View in: PubMed
    Score: 0.007
  53. Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18. Arthritis Rheumatol. 2019 12; 71(12):2059-2067.
    View in: PubMed
    Score: 0.007
  54. Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease. Clin Exp Rheumatol. 2019 Jul-Aug; 37 Suppl 119(4):115-124.
    View in: PubMed
    Score: 0.006
  55. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Am J Obstet Gynecol. 1999 Sep; 181(3):642-8.
    View in: PubMed
    Score: 0.006
  56. Randomized Controlled Trial to Evaluate an Internet-Based Self-Management Program in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2019 03; 71(3):435-447.
    View in: PubMed
    Score: 0.006
  57. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195.
    View in: PubMed
    Score: 0.006
  58. Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry. J Rheumatol. 2019 02; 46(2):176-183.
    View in: PubMed
    Score: 0.006
  59. Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans. Arthritis Rheumatol. 2018 10; 70(10):1654-1660.
    View in: PubMed
    Score: 0.006
  60. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. N Engl J Med. 2018 01 04; 378(1):35-47.
    View in: PubMed
    Score: 0.006
  61. Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations. PLoS One. 2018; 13(1):e0189498.
    View in: PubMed
    Score: 0.006
  62. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database. Medicine (Baltimore). 2017 Dec; 96(51):e8980.
    View in: PubMed
    Score: 0.006
  63. Prednisone and aspirin in women with recurrent fetal loss. N Engl J Med. 1997 Nov 27; 337(22):1629-30.
    View in: PubMed
    Score: 0.006
  64. Recent attempted and actual weight change in relation to pregnancy loss: a prospective cohort study. BJOG. 2018 May; 125(6):676-684.
    View in: PubMed
    Score: 0.006
  65. There is a need for new systemic sclerosis subset criteria. A content analytic approach. Scand J Rheumatol. 2018 Jan; 47(1):62-70.
    View in: PubMed
    Score: 0.006
  66. Symptomatic spinal calcinosis in systemic sclerosis (scleroderma). Arthritis Rheum. 1997 Oct; 40(10):1892-5.
    View in: PubMed
    Score: 0.006
  67. Variable effects on murine pregnancy of immunoglobulin G fractions from women with antiphospholipid antibodies. Am J Obstet Gynecol. 1997 Jul; 177(1):229-33.
    View in: PubMed
    Score: 0.006
  68. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2017 May; 14(5):682-689.
    View in: PubMed
    Score: 0.006
  69. Transforming growth factor ?1 (TGF?1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis. J Biol Chem. 2017 06 23; 292(25):10490-10519.
    View in: PubMed
    Score: 0.005
  70. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum. 1997 Apr; 40(4):743-51.
    View in: PubMed
    Score: 0.005
  71. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies. Am J Obstet Gynecol. 1997 Mar; 176(3):628-33.
    View in: PubMed
    Score: 0.005
  72. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):106-113.
    View in: PubMed
    Score: 0.005
  73. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017 Aug; 76(8):1327-1339.
    View in: PubMed
    Score: 0.005
  74. Scleroderma. Clinical problems. The lungs. Rheum Dis Clin North Am. 1996 Nov; 22(4):825-40.
    View in: PubMed
    Score: 0.005
  75. Paul Klee and scleroderma. Bull Rheum Dis. 1996 Oct; 45(6):4-6.
    View in: PubMed
    Score: 0.005
  76. Pathophysiology of the eosinophilia-myalgia syndrome. J Rheumatol Suppl. 1996 Oct; 46:26-36.
    View in: PubMed
    Score: 0.005
  77. D1398G Variant of MET Is Associated with Impaired Signaling of Hepatocyte Growth Factor in Alveolar Epithelial Cells and Lung Fibroblasts. PLoS One. 2016; 11(9):e0162357.
    View in: PubMed
    Score: 0.005
  78. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719.
    View in: PubMed
    Score: 0.005
  79. Anticardiolipin antibodies: clinical consequences of "low titers". Obstet Gynecol. 1996 Apr; 87(4):494-500.
    View in: PubMed
    Score: 0.005
  80. Systemic Sclerosis and Perceptions of Quality in Primary Care. Am J Med Sci. 2016 05; 351(5):447-51.
    View in: PubMed
    Score: 0.005
  81. Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients. Arthritis Res Ther. 2016 Jan 20; 18:20.
    View in: PubMed
    Score: 0.005
  82. M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo. Transl Res. 2016 Apr; 170:99-111.
    View in: PubMed
    Score: 0.005
  83. Unusual pleuroamniotic shunt complication managed using a two-port in-CO2 fetoscopic technique: technical and ethical considerations. Ultrasound Obstet Gynecol. 2016 Jan; 47(1):123-4.
    View in: PubMed
    Score: 0.005
  84. Genetics of systemic sclerosis: recent advances. Curr Opin Rheumatol. 2015 Nov; 27(6):521-9.
    View in: PubMed
    Score: 0.005
  85. Scleroderma: diagnosis and treatment, Circa 1995. Bull Rheum Dis. 1995 Oct; 44(6):2-5.
    View in: PubMed
    Score: 0.005
  86. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol. 1995 Oct; 22(10):1876-83.
    View in: PubMed
    Score: 0.005
  87. Eosinophilia-myalgia syndrome: a long-term follow-up study. South Med J. 1995 Sep; 88(9):953-8.
    View in: PubMed
    Score: 0.005
  88. Maternal thrombocytopenia in pregnancy: time for a reassessment. Am J Obstet Gynecol. 1995 Aug; 173(2):479-82.
    View in: PubMed
    Score: 0.005
  89. Electron probe microanalysis of silicon and the role of the macrophage in proximal (capsule) and distant sites in augmentation mammaplasty patients. Plast Reconstr Surg. 1995 Mar; 95(3):513-9.
    View in: PubMed
    Score: 0.005
  90. Systemic sclerosis (scleroderma). Clinical management of its major complications. Rheum Dis Clin North Am. 1995 Feb; 21(1):203-16.
    View in: PubMed
    Score: 0.005
  91. Interstitial lung disease of systemic sclerosis. Int Rev Immunol. 1995; 12(2-4):281-91.
    View in: PubMed
    Score: 0.005
  92. Antinuclear antibody-negative systemic sclerosis. Semin Arthritis Rheum. 2015 Jun; 44(6):680-6.
    View in: PubMed
    Score: 0.005
  93. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol. 1994 Nov; 6(6):642-9.
    View in: PubMed
    Score: 0.005
  94. An automatic female pelvic medicine and reconstructive surgery registry and complications manager developed in an electronic medical record. Female Pelvic Med Reconstr Surg. 2014 Nov-Dec; 20(6):302-4.
    View in: PubMed
    Score: 0.005
  95. The eosinophilia-myalgia syndrome. Clin Dermatol. 1994 Jul-Sep; 12(3):457-65.
    View in: PubMed
    Score: 0.005
  96. Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease. Arthritis Rheumatol. 2014 Jul; 66(7):1909-19.
    View in: PubMed
    Score: 0.005
  97. Thrombin increases lung fibroblast survival while promoting alveolar epithelial cell apoptosis via the endoplasmic reticulum stress marker, CCAAT enhancer-binding homologous protein. Am J Respir Cell Mol Biol. 2014 May; 50(5):893-902.
    View in: PubMed
    Score: 0.004
  98. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. J Clin Epidemiol. 2014 Jun; 67(6):706-14.
    View in: PubMed
    Score: 0.004
  99. Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease. Curr Rheumatol Rep. 2014 Apr; 16(4):411.
    View in: PubMed
    Score: 0.004
  100. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care Res (Hoboken). 2014 Mar; 66(3):489-95.
    View in: PubMed
    Score: 0.004
  101. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol. 1994 Mar; 83(3):372-7.
    View in: PubMed
    Score: 0.004
  102. Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2014 Apr 15; 306(8):L736-48.
    View in: PubMed
    Score: 0.004
  103. Rationale for anticoagulant therapy of pulmonary fibrosis. Am J Respir Crit Care Med. 2014 Feb 01; 189(3):362-3.
    View in: PubMed
    Score: 0.004
  104. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet. 2014 Jan 02; 94(1):47-61.
    View in: PubMed
    Score: 0.004
  105. Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-?1 signaling in interstitial lung disease. J Biol Chem. 2014 Mar 14; 289(11):7856-72.
    View in: PubMed
    Score: 0.004
  106. Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative. Clin Exp Rheumatol. 2014 Nov-Dec; 32(6 Suppl 86):S-21-7.
    View in: PubMed
    Score: 0.004
  107. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol. 1993 Nov; 5(6):802-8.
    View in: PubMed
    Score: 0.004
  108. Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: preeclampsia, small-for-gestational-age fetus, and premature labor. Am J Obstet Gynecol. 1993 Nov; 169(5):1101-5.
    View in: PubMed
    Score: 0.004
  109. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013 Nov; 72(11):1747-55.
    View in: PubMed
    Score: 0.004
  110. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013 Nov; 65(11):2737-47.
    View in: PubMed
    Score: 0.004
  111. Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med. 1993 Oct; 95(4):413-8.
    View in: PubMed
    Score: 0.004
  112. Differential regulation of cell functions by CSD peptide subdomains. Respir Res. 2013 Sep 08; 14:90.
    View in: PubMed
    Score: 0.004
  113. Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress. Placenta. 1993 Sep-Oct; 14(5):583-9.
    View in: PubMed
    Score: 0.004
  114. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol. 1993 May; 20(5):838-44.
    View in: PubMed
    Score: 0.004
  115. Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension. Am J Pathol. 2013 Jun; 182(6):2391-406.
    View in: PubMed
    Score: 0.004
  116. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements. 2013 Mar 06; 29(1):1-31.
    View in: PubMed
    Score: 0.004
  117. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis. 2014 Mar; 73(3):557-66.
    View in: PubMed
    Score: 0.004
  118. Lung disease in systemic sclerosis (scleroderma). Baillieres Clin Rheumatol. 1993 Feb; 7(1):79-97.
    View in: PubMed
    Score: 0.004
  119. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 2013; 22(12):2267-77.
    View in: PubMed
    Score: 0.004
  120. Demonstration of silicon in sites of connective-tissue disease in patients with silicone-gel breast implants. Arch Dermatol. 1993 Jan; 129(1):63-8.
    View in: PubMed
    Score: 0.004
  121. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol. 1992 Dec; 4(6):851-6.
    View in: PubMed
    Score: 0.004
  122. Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma. J Rheumatol. 1992 Nov; 19(11):1716-23.
    View in: PubMed
    Score: 0.004
  123. The health education for lupus study: a randomized controlled cognitive-behavioral intervention targeting psychosocial adjustment and quality of life in adolescent females with systemic lupus erythematosus. Am J Med Sci. 2012 Oct; 344(4):274-82.
    View in: PubMed
    Score: 0.004
  124. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. Arthritis Rheum. 1992 Sep; 35(9):1097-105.
    View in: PubMed
    Score: 0.004
  125. Life-threatening puerperal infection due to group A streptococci. Obstet Gynecol. 1992 May; 79(5 ( Pt 2)):894-6.
    View in: PubMed
    Score: 0.004
  126. Antiphospholipid antibodies and fetal loss. N Engl J Med. 1992 Apr 02; 326(14):952; author reply 953-4.
    View in: PubMed
    Score: 0.004
  127. Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken). 2012 Mar; 64(3):351-7.
    View in: PubMed
    Score: 0.004
  128. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. J Rheumatol. 1992 Jan; 19(1):69-73.
    View in: PubMed
    Score: 0.004
  129. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum. 2012 Jan; 64(1):285-96.
    View in: PubMed
    Score: 0.004
  130. Clinical aspects of localized and systemic scleroderma. Curr Opin Rheumatol. 1991 Dec; 3(6):973-8.
    View in: PubMed
    Score: 0.004
  131. Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis. 1991 Nov; 50 Suppl 4:854-61.
    View in: PubMed
    Score: 0.004
  132. Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. Am J Med Sci. 2011 Nov; 342(5):352-5.
    View in: PubMed
    Score: 0.004
  133. High resolution computed tomography in early scleroderma lung disease. J Rheumatol. 1991 Oct; 18(10):1520-8.
    View in: PubMed
    Score: 0.004
  134. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis. J Rheumatol. 2011 Aug; 38(8):1622-30.
    View in: PubMed
    Score: 0.004
  135. CD163 and its role in inflammation. Folia Histochem Cytobiol. 2011; 49(3):365-74.
    View in: PubMed
    Score: 0.004
  136. Coagulation and autoimmunity in scleroderma interstitial lung disease. Semin Arthritis Rheum. 2011 Oct; 41(2):212-22.
    View in: PubMed
    Score: 0.004
  137. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus. 2010 Oct; 19(11):1315-25.
    View in: PubMed
    Score: 0.003
  138. Preschool sarcoidosis masquerading as juvenile rheumatoid arthritis: two case reports and a review of the literature. Pediatr Dermatol. 1990 Sep; 7(3):208-13.
    View in: PubMed
    Score: 0.003
  139. Lymphokine activated killer (LAK) cell activity in the peripheral blood lymphocytes of systemic sclerosis (SSc) patients. Clin Exp Rheumatol. 1990 Sep-Oct; 8(5):481-6.
    View in: PubMed
    Score: 0.003
  140. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010 Aug; 62(8):2467-75.
    View in: PubMed
    Score: 0.003
  141. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus. 2010 Nov; 19(13):1502-14.
    View in: PubMed
    Score: 0.003
  142. Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials. Clin Exp Rheumatol. 2010 Mar-Apr; 28(2 Suppl 58):S55-62.
    View in: PubMed
    Score: 0.003
  143. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol. 2010 Jul; 37(7):1488-501.
    View in: PubMed
    Score: 0.003
  144. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med. 1990 May; 88(5):470-6.
    View in: PubMed
    Score: 0.003
  145. Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease. Ann Rheum Dis. 2010 Jun; 69(6):1220-6.
    View in: PubMed
    Score: 0.003
  146. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med. 1990 Mar 29; 322(13):874-81.
    View in: PubMed
    Score: 0.003
  147. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol. 2010 Apr; 176(4):1983-98.
    View in: PubMed
    Score: 0.003
  148. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity. Am Rev Respir Dis. 1990 Feb; 141(2):301-6.
    View in: PubMed
    Score: 0.003
  149. Lung involvement in systemic sclerosis. Rheum Dis Clin North Am. 1990 Feb; 16(1):199-216.
    View in: PubMed
    Score: 0.003
  150. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis. Am J Med. 1989 Nov; 87(5):525-7.
    View in: PubMed
    Score: 0.003
  151. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol. 2009 Oct; 201(4):375.e1-8.
    View in: PubMed
    Score: 0.003
  152. A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer? Arthritis Rheum. 1989 Jul; 32(7):817-25.
    View in: PubMed
    Score: 0.003
  153. D-penicillamine-induced elastosis perforans serpiginosa in a child with juvenile rheumatoid arthritis. Report of a case and review of the literature. J Am Acad Dermatol. 1989 May; 20(5 Pt 2):979-88.
    View in: PubMed
    Score: 0.003
  154. Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma. Arthritis Rheum. 1989 May; 32(5):577-83.
    View in: PubMed
    Score: 0.003
  155. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009 May; 60(5):1496-507.
    View in: PubMed
    Score: 0.003
  156. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009 Apr; 60(4):1102-11.
    View in: PubMed
    Score: 0.003
  157. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol. 2009 Apr; 36(4):773-80.
    View in: PubMed
    Score: 0.003
  158. Childhood dermatomyositis: serial microvascular studies. Pediatrics. 1989 Feb; 83(2):278-83.
    View in: PubMed
    Score: 0.003
  159. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol. 2009 Feb; 36(2):330-6.
    View in: PubMed
    Score: 0.003
  160. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis. 2009 May; 68(5):620-8.
    View in: PubMed
    Score: 0.003
  161. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. Ann Rheum Dis. 2009 May; 68(5):629-34.
    View in: PubMed
    Score: 0.003
  162. Nonsteroidal anti-inflammatory drugs in the management of juvenile arthritis. J Clin Pharmacol. 1988 Jun; 28(6):566-70.
    View in: PubMed
    Score: 0.003
  163. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 2008 May; 294(5):L843-61.
    View in: PubMed
    Score: 0.003
  164. A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol. 2007 Oct; 197(4):396.e1-9.
    View in: PubMed
    Score: 0.003
  165. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):91-8.
    View in: PubMed
    Score: 0.003
  166. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):1026-34.
    View in: PubMed
    Score: 0.003
  167. Interstitial lung disease in systemic sclerosis. Lung. 2007 Jul-Aug; 185(4):211-20.
    View in: PubMed
    Score: 0.003
  168. Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis. J Rheumatol. 2007 Jun; 34(6):1277-82.
    View in: PubMed
    Score: 0.003
  169. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 2007 Dec; 66(12):1641-7.
    View in: PubMed
    Score: 0.003
  170. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum. 2007 May; 56(5):1676-84.
    View in: PubMed
    Score: 0.003
  171. Tumoral calcinosis presenting as adhesive capsulitis: case report and literature review. Arthritis Rheum. 1987 Apr; 30(4):455-9.
    View in: PubMed
    Score: 0.003
  172. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2655-66.
    View in: PubMed
    Score: 0.003
  173. Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid. Arthritis Rheum. 1986 Apr; 29(4):525-31.
    View in: PubMed
    Score: 0.003
  174. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol. 2005 Oct; 32(10):1888-92.
    View in: PubMed
    Score: 0.002
  175. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum. 2005 Aug; 52(8):2425-32.
    View in: PubMed
    Score: 0.002
  176. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol. 2005 May; 32(5):832-40.
    View in: PubMed
    Score: 0.002
  177. Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. J Biol Chem. 2005 Apr 08; 280(14):13879-87.
    View in: PubMed
    Score: 0.002
  178. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005 Feb; 52(2):592-600.
    View in: PubMed
    Score: 0.002
  179. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum. 1984 Nov; 27(11):1254-62.
    View in: PubMed
    Score: 0.002
  180. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis. Clin Exp Rheumatol. 2004 Nov-Dec; 22(6):733-42.
    View in: PubMed
    Score: 0.002
  181. Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol. 2005 Jan; 288(1):L190-201.
    View in: PubMed
    Score: 0.002
  182. D-penicillamine induced polymyositis in juvenile chronic arthritis: report of a case. J Rheumatol. 1984 Apr; 11(2):251-2.
    View in: PubMed
    Score: 0.002
  183. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol. 2004 Jul; 31(1):28-35.
    View in: PubMed
    Score: 0.002
  184. Ethnic differences in cytotoxic T lymphocyte associated antigen 4 genotype associations with systemic sclerosis. J Rheumatol. 2004 Jan; 31(1):85-7.
    View in: PubMed
    Score: 0.002
  185. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities. J Rheumatol. 2003 Nov; 30(11):2392-7.
    View in: PubMed
    Score: 0.002
  186. First-trimester screening for trisomies 21 and 18. N Engl J Med. 2003 Oct 09; 349(15):1405-13.
    View in: PubMed
    Score: 0.002
  187. Wegener's granulomatosis in patients with rheumatoid arthritis. J Rheumatol. 2003 Sep; 30(9):2064-9.
    View in: PubMed
    Score: 0.002
  188. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol. 2003 Aug; 163(2):571-81.
    View in: PubMed
    Score: 0.002
  189. Contractile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myofibroblasts. Am J Physiol Lung Cell Mol Physiol. 2003 Aug; 285(2):L334-43.
    View in: PubMed
    Score: 0.002
  190. The medical management of rheumatoid arthritis. J S C Med Assoc. 1982 Nov; 78(11):593-8.
    View in: PubMed
    Score: 0.002
  191. Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted. Exp Clin Immunogenet. 2001; 18(3):123-9.
    View in: PubMed
    Score: 0.002
  192. Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum. 2000 Feb; 43(2):243-9.
    View in: PubMed
    Score: 0.002
  193. Solvent oriented hobbies and the risk of systemic sclerosis. J Rheumatol. 1999 Nov; 26(11):2369-72.
    View in: PubMed
    Score: 0.002
  194. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol. 1999 Jul 15; 163(2):1066-72.
    View in: PubMed
    Score: 0.002
  195. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998 Jun; 41(6):1111-8.
    View in: PubMed
    Score: 0.001
  196. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction. Am J Reprod Immunol. 1998 May; 39(5):310-5.
    View in: PubMed
    Score: 0.001
  197. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstet Gynecol Surv. 1997 Mar; 52(3):193-7.
    View in: PubMed
    Score: 0.001
  198. Antiphospholipid antibodies in healthy pregnant women. Rheum Dis Clin North Am. 1997 Feb; 23(1):55-70.
    View in: PubMed
    Score: 0.001
  199. Antiphospholipid antibodies in patients with eosinophilia myalgia and toxic oil syndrome. J Rheumatol. 1997 Jan; 24(1):69-72.
    View in: PubMed
    Score: 0.001
  200. Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome. Int J Biochem Cell Biol. 1997 Jan; 29(1):135-41.
    View in: PubMed
    Score: 0.001
  201. Cyclosporin A inhibits prostaglandin E2 production by fetal amnion cells in response to various stimuli. Prostaglandins. 1996 Jul; 52(1):51-61.
    View in: PubMed
    Score: 0.001
  202. Antiphospholipid antibodies and fetal death. Obstet Gynecol. 1996 Apr; 87(4):489-93.
    View in: PubMed
    Score: 0.001
  203. The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. Ann Intern Med. 1995 Jun 01; 122(11):851-5.
    View in: PubMed
    Score: 0.001
  204. The eosinophilia-myalgia syndrome--guidelines for patient care. J Rheumatol. 1995 Jan; 22(1):161-3.
    View in: PubMed
    Score: 0.001
  205. Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene). J Rheumatol. 1994 Aug; 21(8):1567-70.
    View in: PubMed
    Score: 0.001
  206. Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor. Am J Respir Cell Mol Biol. 1994 Apr; 10(4):405-12.
    View in: PubMed
    Score: 0.001
  207. Cyclosporin A attenuates increased prostaglandin and thromboxane production in response to various stimuli in human decidua. Am J Reprod Immunol. 1993 Sep-Oct; 30(2-3):154-9.
    View in: PubMed
    Score: 0.001
  208. Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR Am J Roentgenol. 1993 Aug; 161(2):269-72.
    View in: PubMed
    Score: 0.001
  209. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 1992 Oct; 80(4):614-20.
    View in: PubMed
    Score: 0.001
  210. Scleroderma following augmentation mammoplasty. Report of a case and review of the literature. Arch Dermatol. 1990 Sep; 126(9):1198-202.
    View in: PubMed
    Score: 0.001
  211. Spontaneous dissection of the internal carotid artery in a patient with polyarteritis nodosa. Arthritis Rheum. 1989 Dec; 32(12):1625-6.
    View in: PubMed
    Score: 0.001
  212. Familial clustering of scleroderma spectrum disease. Am J Med. 1988 Jun; 84(6):1023-32.
    View in: PubMed
    Score: 0.001
  213. Depression by Fc gamma receptor ligands of SRBC-induced IgM-PFC generation in human blood mononuclear cell cultures. Diagn Clin Immunol. 1988; 5(6):304-8.
    View in: PubMed
    Score: 0.001
  214. Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation. Hematol Oncol. 1988 Jan-Mar; 6(1):7-12.
    View in: PubMed
    Score: 0.001
  215. Mononuclear cells from rheumatoid arthritis patients exhibit a depressed IgM response to sheep erythrocyte stimulation in vitro. Diagn Clin Immunol. 1988; 5(5):266-8.
    View in: PubMed
    Score: 0.001
  216. Dipyridamole decreases platelet-derived growth factor levels in human serum. Arteriosclerosis. 1987 Mar-Apr; 7(2):152-8.
    View in: PubMed
    Score: 0.001
  217. Anticentromere antibody and immunoglobulin allotypes in scleroderma. Arch Dermatol. 1985 Mar; 121(3):339-44.
    View in: PubMed
    Score: 0.001
  218. Direct and indirect immunofluorescent findings in dermatomyositis. J Cutan Pathol. 1985 Feb; 12(1):18-27.
    View in: PubMed
    Score: 0.001
  219. Fibronectin distribution in nailfold biopsies of scleroderma (systemic sclerosis) patients. Acta Derm Venereol. 1985; 65(3):185-9.
    View in: PubMed
    Score: 0.001
  220. Epidermal nuclear immunofluorescence: serological correlations supporting an in vivo reaction. Br J Dermatol. 1985 Jan; 112(1):15-22.
    View in: PubMed
    Score: 0.001
  221. Immunofluorescence in skin specimens from three different biopsy sites in patients with scleroderma. Clin Exp Rheumatol. 1985 Jan-Mar; 3(1):11-6.
    View in: PubMed
    Score: 0.001
  222. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med. 1984 Nov; 77(5):812-22.
    View in: PubMed
    Score: 0.001
  223. Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma. J Am Acad Dermatol. 1984 Sep; 11(3):461-7.
    View in: PubMed
    Score: 0.001
  224. Serial changes in nailfold capillary morphology in childhood dermatomyositis. Arthritis Rheum. 1983 Sep; 26(9):1169-72.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.